Cuprina Holdings (Cayman) LTD (NASDAQ:CUPR) Short Interest Up 195.2% in May

Cuprina Holdings (Cayman) LTD (NASDAQ:CUPR) saw a large growth in short interest during the month of May. As of May 15th, there was short interest totaling 278,140 shares, a growth of 195.2% from the April 30th total of 94,217 shares. Based on an average trading volume of 1,597,098 shares, the days-to-cover ratio is currently 0.2 days. Currently, 1.3% of the shares of the stock are short sold.

Cuprina Holdings (Cayman) Stock Performance

CUPR stock traded down $0.92 during trading hours on Friday, hitting $2.39. The company’s stock had a trading volume of 292,379 shares, compared to its average volume of 283,651. The stock has a 50 day moving average of $2.53. Cuprina Holdings has a 12 month low of $1.76 and a 12 month high of $76.00. The company has a quick ratio of 2.35, a current ratio of 2.35 and a debt-to-equity ratio of 0.07.

Cuprina Holdings (Cayman) (NASDAQ:CUPR) last announced its quarterly earnings results on Monday, April 27th. The company reported ($0.40) EPS for the quarter. The firm had revenue of $0.01 million for the quarter.

Analyst Ratings Changes

Separately, Weiss Ratings restated a “sell (e+)” rating on shares of Cuprina Holdings (Cayman) in a report on Friday, April 24th. One research analyst has rated the stock with a Sell rating, According to data from MarketBeat, the company has a consensus rating of “Sell”.

About Cuprina Holdings (Cayman)

We are a Singapore-based biomedical and biotechnology company that is dedicated to the development and commercialization of innovative products for the management of chronic wounds, as well as operating in the health and beauty sectors. Our expertise in biomedical research allows us to identify and utilize materials derived from natural sources to develop wound care products in the form of medical devices which meet international standards. We believe we will be able to build upon and leverage such expertise to develop innovative cosmeceutical products in the future.